Literature DB >> 1349624

Substituent effects in the free radical reactions of silybin: radiation-induced oxidation of the flavonoid at neutral pH.

I György1, S Antus, A Blázovics, G Földiák.   

Abstract

Silybin dihemisuccinate sodium salt, a flavonoid used in human therapy of liver dysfunction, has an inhibitory effect in vivo on radiation-induced deactivation of enzymes and peroxidation of membrane lipids in rat liver microsomes. The reactivity of silybin and its phenolic OH groups towards free radicals (OH, N3., (SCN)2.-, Cl3CO2.) in aqueous solution was studied by pulse radiolysis. Absorption spectra for the phenoxyl-type radicals were assigned using structurally similar models. The one-electron reduction potential for silybin at pH 7 (E07 = 0.76 V), determined using the p-methoxy-phenoxyl/phenolate redox couple as reference standard (E07 = 0.72 V, Lind et al. 1990), is related to the 3'-methoxy-4'-OH structure, the exclusive target for one-electron oxidation at pH 7, while the 7-OH and 5-OH groups are prevented from oxidation by 4-keto substitution and intramolecular H-bonding, respectively. The free radical reactivity of silybin compares favourably with poly-OH-substituted flavonoids; however, the latter compounds have been reported to generate potentially toxic oxygen species at a biologically relevant pH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349624     DOI: 10.1080/09553009214551411

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  5 in total

1.  Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

Authors:  Sarah J Schrieber; Roy L Hawke; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Catherine M Meyers; Edward Doo; Michael W Fried
Journal:  Drug Metab Dispos       Date:  2011-08-24       Impact factor: 3.922

Review 2.  Silymarin for HCV infection.

Authors:  Stephen J Polyak; Nicholas H Oberlies; Eve-Isabelle Pécheur; Harel Dahari; Peter Ferenci; Jean-Michel Pawlotsky
Journal:  Antivir Ther       Date:  2012-09-25

3.  An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin.

Authors:  Rahul Kumar; Gagan Deep; Rajesh Agarwal
Journal:  Curr Pharmacol Rep       Date:  2015-06-01

4.  Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD.

Authors:  Ying Xie; Sonia R Miranda; Janelle M Hoskins; Roy L Hawke
Journal:  Molecules       Date:  2017-01-15       Impact factor: 4.411

5.  Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship.

Authors:  Chapla Agarwal; Ritambhara Wadhwa; Gagan Deep; David Biedermann; Radek Gažák; Vladimír Křen; Rajesh Agarwal
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.